Action Modules on Resilience and Psychological Health

December 16, 2021 updated by: Hsiang Chu Pai, Chung Shan Medical University

Effect of Action Modules on Resilience and Psychological Health of Stroke Patients

This study aimed to determine whether interventions that use the Specific Thematic Nursing Care Action Modules (STNC-AM) platform improve patients' psychological health over a two-month period.

Study Overview

Status

Completed

Conditions

Detailed Description

The STNC-AM platform that investigator present here is an educational program that integrates education and coaching. STNC-AM has six key aspects: stroke prevention, management of emotions, management of fatigue, physical activity, caregiver training, and integrative resources. Each scope contains detailed care guidance. The nurse coaching component was based on the six key aspects detailed above. This online platform can guide nurses' health education for the comprehensive care of stroke patients.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taichung, Taiwan, 40201
        • Chung Shan Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • remaining hospitalized within 6 months after a stroke attack.
  • being able to communicate verbally.
  • being willing to participate.

Exclusion Criteria:

  • Aphasia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Participants in the experimental group were provided an education program through the Care Action Module during their hospitalization period, and follow-up was conducted one and two months after discharge.

The STNC-AM platform that investigators present here is an educational program that integrates education and coaching.

The nurse coaching component was based on the STNC-AM platform. This online platform can guide nurses' health education for the comprehensive care of stroke patients. Nurses can use an iPad and enter the STNC-AM platform website, where they can directly access the Care Action Module.

No Intervention: Control group
The control group received no intervention, except for the regular care followed by the nurses in general in the rehabilitation ward.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Illness Perception_change is being assessed
Time Frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.

Investigators used the Illness Perception Questionnaire-Revised (IPQ-R) to evaluate stroke patients' positive illness representation.

Investigators used the three positive domains (personal control, treatment control, and illness coherence) of illness representation to evaluate stroke patients' positive illness representation. Total scores ranged from 16 to 80 in each domain. High scores on all three dimensions (personal control, treatment control, and illness coherence) indicated a more positive illness representation.

The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.
Depression and Anxiety_change is being assessed
Time Frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.
Investigators used the Hospital Anxiety and Depression Scale (HADS) to evaluate stroke patients' depression and anxiety.Total scores ranged from 0 to 21 in each domain, and higher scores indicated higher anxiety or depression.
The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.
Resilience_change is being assessed
Time Frame: The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.
Investigators used the Resilience Scale (RS) to evaluate stroke patients' resilience.Total scores ranged from 25 to 175, with higher scores as indicating greater resilience
The data collection was conducted at three time points: first week (baseline; Time 1) of admission to the rehabilitation ward and then first month (Time 2) and second month (Time 3) follow-up after discharge.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

February 28, 2021

Study Registration Dates

First Submitted

December 4, 2021

First Submitted That Met QC Criteria

December 16, 2021

First Posted (Actual)

January 4, 2022

Study Record Updates

Last Update Posted (Actual)

January 4, 2022

Last Update Submitted That Met QC Criteria

December 16, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke Patients

Subscribe